BKYI - Company ID 0001019034
The table below shows BIO KEY INTERNATIONAL INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$4.67M | -$2.91M | -$3.79M | -$6.23M | -$8.98M | -$4.95M |
| Capital expenditure | $12.01K | $13.05K | $1.00K | $82.04K | $42.02K | $35.57K |
| Investing cash flow | -$12.01K | -$13.05K | -$1.00K | -$696.62K | -$42.02K | -$2.23M |
| Dividends paid | - | - | - | - |
BIO KEY INTERNATIONAL INC reported operating cash flow of -$4.67M for fiscal year 2025. That is down 60.2% from -$2.91M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$4.45M (FY 2016) to -$4.67M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $6.91M | $2.83M | $1.43M | $1.90M | -$218.60K | $24.09M |